However, long-term Aricept treatment was associated with more significant amyloid load and tau burden in the temporal lobe, posterior cingulate, parahippocampal gyrus, and worse cognitive performance among individuals with mild cognitive impairment (Li, et al., 2022). Here, MAPT is linked to Cognitive impairment.